{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:39:53Z","timestamp":1783561193618,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,9,17]],"date-time":"2008-09-17T00:00:00Z","timestamp":1221609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/npp.2008.142","type":"journal-article","created":{"date-parts":[[2008,9,18]],"date-time":"2008-09-18T08:43:39Z","timestamp":1221727419000},"page":"775-785","source":"Crossref","is-referenced-by-count":141,"title":["Prodynorphin-Derived Peptides Are Critical Modulators of Anxiety and Regulate Neurochemistry and Corticosterone"],"prefix":"10.1038","volume":"34","author":[{"given":"Walter","family":"Wittmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Schunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Rosskothen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Gaburro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Singewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schwarzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,17]]},"reference":[{"key":"BFnpp2008142_CR1","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/0031-9384(96)00156-4","volume":"60","author":"MS Aguiar","year":"1996","unstructured":"Aguiar MS, Brandao ML (1996). Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test. Physiol Behav 60: 1183\u20131186.","journal-title":"Physiol Behav"},{"key":"BFnpp2008142_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbr.2007.08.029","volume":"187","author":"H Bachli","year":"2008","unstructured":"Bachli H, Steiner MA, Habersetzer U, Wotjak CT (2008). Increased water temperature renders single-housed C57BL\/6J mice susceptible to antidepressant treatment in the forced swim test. Behav Brain Res 187: 67\u201371.","journal-title":"Behav Brain Res"},{"key":"BFnpp2008142_CR3","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/74263","volume":"24","author":"TL Bale","year":"2000","unstructured":"Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE et al (2000). Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24: 410\u2013414.","journal-title":"Nat Genet"},{"key":"BFnpp2008142_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.psyneuen.2007.12.010","volume":"33","author":"A Bilkei-Gorzo","year":"2008","unstructured":"Bilkei-Gorzo A, Racz I, Michel K, Mauer D, Zimmer A, Klingmuller D et al (2008). Control of hormonal stress reactivity by the endogenous opioid system. Psychoneuroendocrinology 33: 425\u2013436.","journal-title":"Psychoneuroendocrinology"},{"key":"BFnpp2008142_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00004850-200307000-00001","volume":"18","author":"N Brunello","year":"2003","unstructured":"Brunello N, Blier P, Judd LL, Mendlewicz J, Nelson CJ, Souery D et al (2003). Noradrenaline in mood and anxiety disorders: basic and clinical studies. Int Clin Psychopharmacol 18: 191\u2013202.","journal-title":"Int Clin Psychopharmacol"},{"key":"BFnpp2008142_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/74255","volume":"24","author":"SC Coste","year":"2000","unstructured":"Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH et al (2000). Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 24: 403\u2013409.","journal-title":"Nat Genet"},{"key":"BFnpp2008142_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0006-8993(98)01258-X","volume":"835","author":"JN Crawley","year":"1999","unstructured":"Crawley JN (1999). Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835: 18\u201326.","journal-title":"Brain Res"},{"key":"BFnpp2008142_CR8","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.1073\/pnas.0400794101","volume":"101","author":"K Ebner","year":"2004","unstructured":"Ebner K, Rupniak NM, Saria A, Singewald N (2004). Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proc Natl Acad Sci USA 101: 4280\u20134285.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2008142_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00726-006-0335-9","volume":"31","author":"K Ebner","year":"2006","unstructured":"Ebner K, Singewald N (2006). The role of substance P in stress and anxiety responses. Amino Acids 31: 251\u2013272.","journal-title":"Amino Acids"},{"key":"BFnpp2008142_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0306-3623(95)02034-9","volume":"27","author":"G Engelhardt","year":"1996","unstructured":"Engelhardt G, Homma D, Schlegel K, Schnitzler C, Utzmann R (1996). General pharmacology of meloxicam\u2014Part I: effects on CNS, gastric emptying, intestinal transport, water, electrolyte and creatinine excretion. Gen Pharmacol 27: 673\u2013677.","journal-title":"Gen Pharmacol"},{"key":"BFnpp2008142_CR11","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1097\/00001756-199911080-00026","volume":"10","author":"EC Gavioli","year":"1999","unstructured":"Gavioli EC, Canteras NS, De Lima TC (1999). Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus. Neuroreport 10: 3399\u20133403.","journal-title":"Neuroreport"},{"key":"BFnpp2008142_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00213-002-1112-4","volume":"163","author":"FG Graeff","year":"2002","unstructured":"Graeff FG (2002). On serotonin and experimental anxiety. Psychopharmacology (Berl) 163: 467\u2013476.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008142_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.brainres.2006.03.026","volume":"1102","author":"M Hamke","year":"2006","unstructured":"Hamke M, Herpfer I, Lieb K, Wandelt C, Fiebich BL (2006). Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor. Brain Res 1102: 135\u2013144.","journal-title":"Brain Res"},{"key":"BFnpp2008142_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0166-2236(94)90079-5","volume":"17","author":"M Heilig","year":"1994","unstructured":"Heilig M, Koob GF, Ekman R, Britton KT (1994). Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 17: 80\u201385.","journal-title":"Trends Neurosci"},{"key":"BFnpp2008142_CR15","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S (1979). A simple sequentially rejective multiple test procedure. Scand J Stat 6: 65\u201370.","journal-title":"Scand J Stat"},{"key":"BFnpp2008142_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0006-8993(01)02624-5","volume":"909","author":"DC Jewett","year":"2001","unstructured":"Jewett DC, Grace MK, Jones RM, Billington CJ, Portoghese PS, Levine AS (2001). The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats. Brain Res 909: 75\u201380.","journal-title":"Brain Res"},{"key":"BFnpp2008142_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0014-2999(00)00208-9","volume":"396","author":"RM Jones","year":"2000","unstructured":"Jones RM, Portoghese PS (2000). 5\u2032-Guanidinonaltrindole, a highly selective and potent kappa-opioid receptor antagonist. Eur J Pharmacol 396: 49\u201352.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2008142_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1078\/0940-2993-00301","volume":"55","author":"T Karl","year":"2003","unstructured":"Karl T, Pabst R, von Horsten S (2003). Behavioral phenotyping of mice in pharmacological and toxicological research. Exp Toxicol Pathol 55: 69\u201383.","journal-title":"Exp Toxicol Pathol"},{"key":"BFnpp2008142_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00213-007-0945-2","volume":"195","author":"RM Karlsson","year":"2008","unstructured":"Karlsson RM, Choe JS, Cameron HA, Thorsell A, Crawley JN, Holmes A et al (2008). The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice. Psychopharmacology (Berl) 195: 547\u2013557.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008142_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0149-7634(01)00066-5","volume":"26","author":"A Kask","year":"2002","unstructured":"Kask A, Harro J, von Horsten S, Redrobe JP, Dumont Y, Quirion R (2002). The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 26: 259\u2013283.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2008142_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0006-8993(99)02383-5","volume":"857","author":"A Kask","year":"2000","unstructured":"Kask A, Schioth HB, Mutulis F, Wikberg JE, Rago L (2000). Anorexigenic cocaine- and amphetamine-regulated transcript peptide intensifies fear reactions in rats. Brain Res 857: 283\u2013285.","journal-title":"Brain Res"},{"key":"BFnpp2008142_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/74271","volume":"24","author":"T Kishimoto","year":"2000","unstructured":"Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F et al (2000). Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 24: 415\u2013419.","journal-title":"Nat Genet"},{"key":"BFnpp2008142_CR23","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1124\/jpet.107.127415","volume":"323","author":"AT Knoll","year":"2007","unstructured":"Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA (2007). Anxiolytic-like effects of {kappa}-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 323: 838\u2013845.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008142_CR24","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.peptides.2004.05.005","volume":"25","author":"NN Kudryavtseva","year":"2004","unstructured":"Kudryavtseva NN, Gerrits MA, Avgustinovich DF, Tenditnik MV, Van Ree JM (2004). Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of mice. Peptides 25: 1355\u20131363.","journal-title":"Peptides"},{"key":"BFnpp2008142_CR25","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/sj.npp.1300959","volume":"31","author":"A Kuzmin","year":"2006","unstructured":"Kuzmin A, Madjid N, Terenius L, Ogren SO, Bakalkin G (2006). Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice. Neuropsychopharmacology 31: 1928\u20131937.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2008142_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","volume":"28","author":"BB Land","year":"2008","unstructured":"Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008). The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28: 407\u2013414.","journal-title":"J Neurosci"},{"key":"BFnpp2008142_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.npep.2005.11.006","volume":"40","author":"S Lin","year":"2006","unstructured":"Lin S, Boey D, Lee N, Schwarzer C, Sainsbury A, Herzog H (2006). Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain. Neuropeptides 40: 115\u2013123.","journal-title":"Neuropeptides"},{"key":"BFnpp2008142_CR28","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/brain\/awl384","volume":"130","author":"S Loacker","year":"2007","unstructured":"Loacker S, Sayyah M, Wittmann W, Herzog H, Schwarzer C (2007). Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors. Brain 130: 1017\u20131028.","journal-title":"Brain"},{"key":"BFnpp2008142_CR29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/cne.21464","volume":"504","author":"NJ Marchant","year":"2007","unstructured":"Marchant NJ, Densmore VS, Osborne PB (2007). Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division. J Comp Neurol 504: 702\u2013715.","journal-title":"J Comp Neurol"},{"key":"BFnpp2008142_CR30","doi-asserted-by":"publisher","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","volume":"23","author":"JP McLaughlin","year":"2003","unstructured":"McLaughlin JP, Marton-Popovici M, Chavkin C (2003). Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23: 5674\u20135683.","journal-title":"J Neurosci"},{"key":"BFnpp2008142_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/sj.npp.1300858","volume":"31","author":"M Narita","year":"2006","unstructured":"Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M et al (2006). Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 31: 739\u2013750.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2008142_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0014-2999(03)01326-8","volume":"463","author":"B Olivier","year":"2003","unstructured":"Olivier B, Zethof T, Pattij T, van Boogaert M, van Oorschot R, Leahy C et al (2003). Stress-induced hyperthermia and anxiety: pharmacological validation. Eur J Pharmacol 463: 117\u2013132.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2008142_CR33","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.2337\/diabetes.51.12.3420","volume":"51","author":"A Sainsbury","year":"2002","unstructured":"Sainsbury A, Schwarzer C, Couzens M, Herzog H (2002). Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob\/ob mice. Diabetes 51: 3420\u20133427.","journal-title":"Diabetes"},{"key":"BFnpp2008142_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.npep.2004.05.006","volume":"38","author":"TJ Sajdyk","year":"2004","unstructured":"Sajdyk TJ, Shekhar A, Gehlert DR (2004). Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides 38: 225\u2013234.","journal-title":"Neuropeptides"},{"key":"BFnpp2008142_CR35","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/sj.bjp.0701394","volume":"122","author":"AN Schoffelmeer","year":"1997","unstructured":"Schoffelmeer AN, Hogenboom F, Mulder AH (1997). Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Br J Pharmacol 122: 520\u2013524.","journal-title":"Br J Pharmacol"},{"key":"BFnpp2008142_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1124\/mol.53.1.6","volume":"53","author":"C Schwarzer","year":"1998","unstructured":"Schwarzer C, Kofler N, Sperk G (1998). Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy. Mol Pharmacol 53: 6\u201313.","journal-title":"Mol Pharmacol"},{"key":"BFnpp2008142_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0169-328X(00)00264-3","volume":"86","author":"N Sharifi","year":"2001","unstructured":"Sharifi N, Diehl N, Yaswen L, Brennan MB, Hochgeschwender U (2001). Generation of dynorphin knockout mice. Brain Res Mol Brain Res 86: 70\u201375.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFnpp2008142_CR38","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0006-8993(00)02019-9","volume":"861","author":"JD Shepard","year":"2000","unstructured":"Shepard JD, Barron KW, Myers DA (2000). Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 861: 288\u2013295.","journal-title":"Brain Res"},{"key":"BFnpp2008142_CR39","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80491-2","volume":"20","author":"GW Smith","year":"1998","unstructured":"Smith GW, Aubry JM, Dellu F, Contarino A, Bilezikjian LM, Gold LH et al (1998). Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20: 1093\u20131102.","journal-title":"Neuron"},{"key":"BFnpp2008142_CR40","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/brain\/awl008","volume":"129","author":"MV Solbrig","year":"2006","unstructured":"Solbrig MV, Adrian R, Baratta J, Lauterborn JC, Koob GF (2006). Kappa opioid control of seizures produced by a virus in an animal model. Brain 129: 642\u2013654.","journal-title":"Brain"},{"key":"BFnpp2008142_CR41","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.peptides.2006.01.027","volume":"27","author":"LM Stanek","year":"2006","unstructured":"Stanek LM (2006). Cocaine- and amphetamine related transcript (CART) and anxiety. Peptides 27: 2005\u20132011.","journal-title":"Peptides"},{"key":"BFnpp2008142_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1749-6632.1996.tb15110.x","volume":"780","author":"MP Stenzel-Poore","year":"1996","unstructured":"Stenzel-Poore MP, Duncan JE, Rittenberg MB, Bakke AC, Heinrichs SC (1996). CRH overproduction in transgenic mice: behavioral and immune system modulation. Ann NY Acad Sci 780: 36\u201348.","journal-title":"Ann NY Acad Sci"},{"key":"BFnpp2008142_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/520","volume":"19","author":"P Timpl","year":"1998","unstructured":"Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK et al (1998). Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19: 162\u2013166.","journal-title":"Nat Genet"},{"key":"BFnpp2008142_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0014-2999(96)00219-1","volume":"307","author":"M Tsuda","year":"1996","unstructured":"Tsuda M, Suzuki T, Misawa M, Nagase H (1996). Involvement of the opioid system in the anxiolytic effect of diazepam in mice. Eur J Pharmacol 307: 7\u201314.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2008142_CR45","first-page":"615","volume":"41","author":"ND Vlachakis","year":"1974","unstructured":"Vlachakis ND, De Guia D, Mendlowitz M, Antram S, Wolf RL (1974). Hypertension and anxiety. A trial with epinephrine and norepinephrine infusion. Mt Sinai J Med 41: 615\u2013625.","journal-title":"Mt Sinai J Med"},{"key":"BFnpp2008142_CR46","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1126\/science.8380941","volume":"259","author":"C Wahlestedt","year":"1993","unstructured":"Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M (1993). Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259: 528\u2013531.","journal-title":"Science"},{"key":"BFnpp2008142_CR47","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1523\/JNEUROSCI.21-05-01779.2001","volume":"21","author":"Z Wang","year":"2001","unstructured":"Wang Z, Gardell LR, Ossipov MH, Vanderah TW, Brennan MB, Hochgeschwender U et al (2001). Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci 21: 1779\u20131786.","journal-title":"J Neurosci"},{"key":"BFnpp2008142_CR48","first-page":"145","volume":"23","author":"HG Westenberg","year":"1987","unstructured":"Westenberg HG, den Boer JA, Kahn RS (1987). Psychopharmacology of anxiety disorders: on the role of serotonin in the treatment of anxiety states and phobic disorders. Psychopharmacol Bull 23: 145\u2013149.","journal-title":"Psychopharmacol Bull"},{"issue":"Suppl","key":"BFnpp2008142_CR49","first-page":"34","volume":"31","author":"CD Wise","year":"1970","unstructured":"Wise CD, Berger BD, Stein L (1970). Serotonin: a possible mediator of behavioral suppression induced by anxiety. Dis Nerv Syst 31 (Suppl): 34\u201337.","journal-title":"Dis Nerv Syst"},{"key":"BFnpp2008142_CR50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.lfs.2003.12.005","volume":"75","author":"M Wollemann","year":"2004","unstructured":"Wollemann M, Benyhe S (2004). Non-opioid actions of opioid peptides. Life Sci 75: 257\u2013270.","journal-title":"Life Sci"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2008142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2008142","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2008142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:17:24Z","timestamp":1684455444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2008142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,17]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BFnpp2008142"],"URL":"https:\/\/doi.org\/10.1038\/npp.2008.142","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,17]]}}}